SCHEMBL7016108

SCHEMBL7016108

CCCn1c(=O)n2cnnc2c2[nH]c(-c3ccccc3OCC)c(Cl)c21.O=S(=O)(Cl)Cl

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 9/20 0.41
PDE1A P54750 4/20 0.39
PDE1B Q01064 4/20 0.39
PDE1C Q14123 4/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 2/20 0.39
USP2 O75604 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ADORA2A P29274 6/20 0.38
ADORA2B P29275 6/20 0.38
ADORA1 P30542 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261819 0.94 PDE5A (0.40) PDE5AALDH1A1KDM4EHSD17B10ADORA2A
SCHEMBL5263574 0.91 PDE5A (0.41) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL5260943 0.87 PDE5A (0.41) PDE5APDE1APDE1BPDE1CKDM4E
SCHEMBL5261815 0.82 PDE5A (0.40) PDE5AADORA2AADORA2BADORA1
SCHEMBL5262492 0.81 PDE5A (0.57) PDE5APDE1APDE1BPDE1CADORA2A
SCHEMBL5261432 0.81 PDE5A (0.49) PDE5APDE1APDE1BPDE1C
SCHEMBL5830709 0.81 PDE5A (0.51) PDE5APDE1APDE1BPDE1C
SCHEMBL5258961 0.81 PDE5A (0.38) PDE5APDE1AKDM4E
SCHEMBL5831211 0.80 PDE5A (0.51) PDE5APDE1APDE1BPDE1CADORA1
SCHEMBL5263571 0.79 PDE5A (0.41) PDE5APDE1APDE1BPDE1CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307458-A1 PYRROLOTRIAZOLOPYRIMIDINONE DERIVATIVES Almirall Prodesfarma, S.A. (ES) 2003-05-07 EP disclosed
WO-2002012246-A1 PYRROLOTRIAZOLOPYRIMIDINONE DERIVATIVES ALMIRALL PRODESFARMA S.A. (ES) 2002-02-14 WO disclosed